Jazz Pharmaceuticals plc
JAZZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $560 | $415 | -$224 | -$330 |
| Dep. & Amort. | $660 | $639 | $629 | $552 |
| Deferred Tax | -$208 | -$260 | -$292 | $69 |
| Stock-Based Comp. | $248 | $227 | $222 | $189 |
| Change in WC | -$77 | -$204 | $10 | -$48 |
| Other Non-Cash | $213 | $276 | $927 | $345 |
| Operating Cash Flow | $1,396 | $1,092 | $1,272 | $779 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$38 | -$24 | -$498 | -$28 |
| Net Acquisitions | $0 | $0 | $53 | -$6,235 |
| Inv. Purchases | -$1,305 | -$390 | -$61 | -$27 |
| Inv. Sales/Matur. | $845 | $270 | $60 | $1,095 |
| Other Inv. Act. | -$10 | -$19 | $0 | -$18 |
| Investing Cash Flow | -$508 | -$163 | -$446 | -$5,212 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $375 | -$31 | -$582 | $3,871 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$311 | -$270 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$43 | -$4 | $53 | $100 |
| Financing Cash Flow | $21 | -$305 | -$529 | $3,971 |
| Forex Effect | -$2 | $1 | -$6 | -$3 |
| Net Chg. in Cash | $907 | $625 | $290 | -$466 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,506 | $881 | $591 | $1,058 |
| End Cash | $2,413 | $1,506 | $881 | $591 |
| Free Cash Flow | $1,348 | $1,068 | $774 | $733 |